Skip to main content
OpenTrials

Clinical trial condition

B-cell Malignancies

Explore clinical trials studying B-cell Malignancies. Study availability and eligibility vary by location and protocol.

18 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

B-cell Malignancies trial results

Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT06542250

Conditions
B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Hackensack, New Jersey, United States
View all 31 locations
View Trial Details
Recruiting

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

NCT07271667

Conditions
B-cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Mt Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Summit Medical Group Florham Park, New Jersey, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions